Perspective Therapeutics, Inc.
For the period ended Apr 15, 2026. Filed Apr 16, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 15, 2026 · Filed Apr 16, 2026
Contents
Code of Ethics
We have adopted a Code of Conduct and Ethics that applies to all of our officers, directors and employees and an additional Code of Ethics for Senior Leadership applicable to our Chief Executive Officer and all Senior Financial Officers that supplements our Code of Conduct and Ethics (together, the “Codes”).
The Codes are available to the public on our website athttps://www.perspectivetherapeutics.com/investors/corporate-governance. Each of these Codes comprises written standards that are reasonably designed to deter wrongdoing and to promote the behavior described in Item 406 of Regulation S-K promulgated by the Securities and Exchange Commission. Any amendments to or waivers of the Codes must be promptly posted on our website at www.perspectivetherapeutics.com or in a Report on Form 8-K, as required by applicable laws. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding any amendment to, or waiver from, a provision of the Codes by posting such information on the website address and location specified above.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.